Arcadia, the leading data analytics platform for healthcare and life sciences, announced its availability through Prognos Marketplace. Prognos is solving for disconnected, siloed data that cannot interoperate and leaves an incomplete view of the patient, including lab results, prescription information, and medical claims. Arcadia is the first source of electronic health record (EHR) data to be included in the platform, delivering deeper clinical insights that will enable Prognos’ life science customers to optimize and accelerate therapy strategies.
Arcadia Research Data is built on an active EHRs and claims-based patient population data that feature comprehensive visibility across payers, multiple sites of care, and the entire clinical patient journey.
Prognos Marketplace will enable linking and access to Arcadia’s de-identified RWD data to drive insights for life sciences research to improve health/patient outcomes.
Recommended AI: SaaS Maker 3 Paves Way for New Era of Software Innovation
“We are pleased to democratize access to health data at scale by joining Prognos’ data partner ecosystem,” said Jim Robbins, SVP of Life Sciences at Arcadia. “The clinical information available in our EHR data will enable these organizations to gather deeper, more accurate medical assessments that can accelerate the advancement of new, life-saving therapies to millions of patients.”
“Prognos’ life science customers can now include Arcadia’s data in their cohort searches and purchase record-level data to inform therapy targeting, map the patient journey, and support therapy launch and commercialization efforts,” said Sundeep Bhan, CEO at Prognos Health. “Providing the ability to combine patients’ data across all data types including lab, claims, pharmacy, EHR, mortality, and SDoH data is critical to improving patient outcomes.”
Recommended AI: Positon Launches PosiVault, an AI-Powered SaaS Application for Programmatic M&A
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.